Why is Australian Clinical Labs contacting individuals regarding SunDoctors?

Australian Clinical Labs (ASX:ACL) is contacting individuals because its subsidiary, SunDoctors, finalised an investigation into an unauthorized third-party cyber incident.

What are the main data categories involved in the SunDoctors incident?

Australian Clinical Labs (ASX:ACL) reported that the vast majority of information involved in the SunDoctors breach consists of basic contact information. Additionally, some health records primarily linked to skin cancer checks and related diagnostic testing were accessed by the unauthorized party.

How is the broader Australian Clinical Labs business impacted by the breach?

The corporate parent stated that the security incident remains strictly limited to a distinct portion of the SunDoctors network. The core pathology and laboratory operations of Australian Clinical Labs (ASX:ACL) across mainland Australia have experienced no disruption or impact from this event.

What does the share price reaction mean for Australian Clinical Labs investors?

Following the operational update regarding the cyber incident at SunDoctors, the Australian Clinical Labs (ASX:ACL) share price moved lower to trade at $2.23. This market movement directly reflects public trading activity and investor response immediately following the company's compliance disclosures.

Image for illustrative purposes only. Not a real photo.

Australian Clinical Labs contacts 280,000 individuals

Q: What is the geographic scale of the SunDoctors network?

The affected subsidiary of Australian Clinical Labs (ASX:ACL) operates a footprint of specialized skin cancer clinics across Queensland, New South Wales, South Australia, and Victoria. Meanwhile, the broader parent entity delivers clinical diagnostic services throughout mainland Australia.

Written by Jon CuthbertPublished Jun 18, 2026, 5:45 AM

Australian Clinical Labs has completed its investigation into a cyber incident affecting its SunDoctors subsidiary.
The company's shares traded lower following the update on the data breach.
SunDoctors is contacting a broad group of individuals out of caution to uphold its regulatory obligations.

Australian Clinical Labs (ASX:ACL) announced it is contacting approximately 280,000 individuals following a cyber incident at its SunDoctors subsidiary.

The announcement follows an initial report on April 30 where an external IT service provider experienced unauthorised access to SunDoctors systems.

An internal investigation confirmed that an unauthorised party accessed the systems and took a small portion of data.

The company stated that the involved data mostly includes basic contact details and health information connected to skin cancer checks.

The company will continue to monitor the situation, and following the announcement, the Australian Clinical Labs share price was down at $2.23.

SunDoctors operates specialised skin cancer clinics across Queensland, New South Wales, South Australia, and Victoria.

The parent business provides pathology services across community, hospital, and other diagnostics segments throughout mainland Australia.

Australian Clinical Labs contacts 280,000 individuals

Frequently asked questions

Assets related to this article